PreClinical CRO dedicated to your NonClinical projects

you are here : REFERENCES > General downloads

ALREADY REGISTERED ?

Username

Password

 Remember me on this computer

Forgot Your Password?
Forgot Your Login Details?



>> Or register yourself



NEWS

Animal models for Parkinson Disease?

We just came back from the last edition of “World Congress on Parkinson’s Disease and Related Disorders” that took place last week on Geneva, Switzerland. This International congress brought together leading clinical and pre-clinical experts, scientists from University


New PAH results with the Monocrotaline model

Pulmonary Arterial Hypertension (PAH) is an orphan disease, incurable that remains highly lethal despite recent advanced medical treatment.


Syncrosome at the Neuroconnection Symposium

Syncrosome invites you to visit us at Neuroconnection in Marseille the 1st and 2nd July. In the framework of the European project NeuroRescue, this symposium is an European event around technological innovation and private-public partnerships in NEUROSCIENCES and AGEING.


Animal models of Diabete?

Diabetes is a chronic metabolic disorder, caused by a failure of the body to produce insulin and/or an inability of the body to respond adequately to circulating insulin. The WHO estimates that 346 million people worldwide have diabetes.




Nota bene : depending on whether
you are identified or not, you have access to a more or less rich content !


 

Download our presentation documents without log in:

(Click once on the magnifying glass to instantly see a preview of the pdf files).


Your partner for in vivo pharmacology outsourced services SYNCROSOME : Your partner for in vivo pharmacology outsourced services

You will find there general informations about our preclinical services in pharmacology for drug development…

 

Overview of pharmacological modelsSYNCROSOME: Overview of pharmacological models

We can provide you with the initial proof of efficacy for Cardiovascular studies. We can evaluate the efficacy of your candidate compound in different models such as Pulmonary Arterial Hypertension, Myocardial ischemia, Arterial hypertension, Heart failure, blood loss…


 

Download our booklets:

(Click once on the magnifying glass to instantly see a preview of the pdf files).

>> You must log in to see this content !

 

CARDIOVASCULAR: models efficacy and safety assessmentCARDIOVASCULAR: models efficacy and safety assessment

We can provide you with the initial proof of efficacy for Cardiovascular studies. We can evaluate the efficacy of your candidate compound in different models such as Pulmonary Arterial Hypertension, Myocardial ischemia, Arterial hypertension, Heart failure, blood loss…


NEURODEGENRATIVE DISORDERS: Central nervous system modelsNEURODEGENERATIVE DISORDERS: Central nervous system (CNS) models

We can provide you with the initial proof of efficacy for CNS studies. We can evaluate the efficacy of your candidate compound in different models such as Parkinson Disease and use Microdialysis to assess the brain level of your compound or neurotransmitters


PHARMACOKINETICS: in vivo PK labPHARMACOKINETICS: in vivo PK lab

You wish to outsource the in vivo phase of your Pharmacokinetic studies to have an idea of the in vivo exposure and determine Basic Pk parameters? We offer you a sélection of various in vivo protocols and species for bioavailibility, Cmax, Tmax …


RESPIRATORY: Pulmonary inflammation efficacy studiesRESPIRATORY: Pulmonary inflammation efficacy studies

We can provide you with the initial proof of efficacy for Respiratory studies. We can evaluate the efficacy of your candidate compound in different models such as Pulmonary Arterial Hypertension, COPD, Asthma, cough…


GASTRO-INTESTINAL: Neurogastroenterology modelsGASTRO-INTESTINAL: Neurogastroenterology models

We can provide you with the initial proof of efficacy for Gastro intestinal studies. We can evaluate the efficacy of your candidate compound in different models such as IBS, IBD, emesis, gastro intestinal transit…

 


 

 

log in  to know more ...